Donald J Wagner, DO | |
1355 Ramar Rd, Ste 11, Bullhead City, AZ 86442-7100 | |
(928) 704-7202 | |
(928) 704-9207 |
Full Name | Donald J Wagner |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 37 Years |
Location | 1355 Ramar Rd, Bullhead City, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134248867 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 3719 (Arizona) | Primary |
207PE0004X | Emergency Medicine - Emergency Medical Services | 3719 (Arizona) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Western Arizona Regional Medical Center | Bullhead city, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bullhead Urgent Care Coporation | 7719962141 | 7 |
Paragon Physical Therapy And Rehab Llc | 4284902339 | 55 |
News Archive
Rep. Michele Bachmann, R-Minn., is asking for a federal audit of her state's Medicaid program after a congressional probe found a year's worth of alleged overpayments. In other news, insurers Molina and Centene have won back Medicaid contracts in Ohio after initially being rejected.
Details of computer models that can predict the chances of a patient responding to their HIV drugs with 80% accuracy are published today in the journal AIDS. The models were developed by the HIV Resistance Response Database Initiative (RDI) using almost half a million pieces of data from approximately 6,000 clinical cases from hundreds of clinics around the world. The models are now available online as part of an experimental treatment support tool, HIV-TRePS.
Medtronic Inc.,and Osteotech, Inc.,today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million.
The Food and Drug Administration may tighten rules for approving medical devices that are only slightly different from already-blessed products, The Chicago Tribune reports.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, and miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA -based therapeutics for cardiovascular and muscle disease, announced today that they have entered into a research collaboration.
› Verified 8 days ago
Entity Name | Bullhead Urgent Care Coporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225158470 PECOS PAC ID: 7719962141 Enrollment ID: O20040621001175 |
News Archive
Rep. Michele Bachmann, R-Minn., is asking for a federal audit of her state's Medicaid program after a congressional probe found a year's worth of alleged overpayments. In other news, insurers Molina and Centene have won back Medicaid contracts in Ohio after initially being rejected.
Details of computer models that can predict the chances of a patient responding to their HIV drugs with 80% accuracy are published today in the journal AIDS. The models were developed by the HIV Resistance Response Database Initiative (RDI) using almost half a million pieces of data from approximately 6,000 clinical cases from hundreds of clinics around the world. The models are now available online as part of an experimental treatment support tool, HIV-TRePS.
Medtronic Inc.,and Osteotech, Inc.,today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million.
The Food and Drug Administration may tighten rules for approving medical devices that are only slightly different from already-blessed products, The Chicago Tribune reports.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, and miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA -based therapeutics for cardiovascular and muscle disease, announced today that they have entered into a research collaboration.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Donald J Wagner, DO 1355 Ramar Rd, Ste 11, Bullhead City, AZ 86442-7100 Ph: (928) 704-7202 | Donald J Wagner, DO 1355 Ramar Rd, Ste 11, Bullhead City, AZ 86442-7100 Ph: (928) 704-7202 |
News Archive
Rep. Michele Bachmann, R-Minn., is asking for a federal audit of her state's Medicaid program after a congressional probe found a year's worth of alleged overpayments. In other news, insurers Molina and Centene have won back Medicaid contracts in Ohio after initially being rejected.
Details of computer models that can predict the chances of a patient responding to their HIV drugs with 80% accuracy are published today in the journal AIDS. The models were developed by the HIV Resistance Response Database Initiative (RDI) using almost half a million pieces of data from approximately 6,000 clinical cases from hundreds of clinics around the world. The models are now available online as part of an experimental treatment support tool, HIV-TRePS.
Medtronic Inc.,and Osteotech, Inc.,today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million.
The Food and Drug Administration may tighten rules for approving medical devices that are only slightly different from already-blessed products, The Chicago Tribune reports.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, and miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA -based therapeutics for cardiovascular and muscle disease, announced today that they have entered into a research collaboration.
› Verified 8 days ago
Ludane Tonie Simmons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Bldg B, Bullhead City, AZ 86442 Phone: 928-763-9290 Fax: 928-763-7628 | |
Summer Charise Aymar, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3641 Highway 95, Bullhead City, AZ 86442 Phone: 928-704-4334 | |
Dr. Kevin Frank Brown, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2812 Silver Creek Rd, Bullhead City, AZ 86442 Phone: 928-763-7404 Fax: 928-763-9795 | |
Nathan Eric Beneze, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Ste A1, Bullhead City, AZ 86442 Phone: 928-704-4499 | |
Freeha Afshin Azher, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3706 Highway 95 Ste 101, Bullhead City, AZ 86442 Phone: 928-201-9286 Fax: 928-219-4610 | |
Mr. Scott Edward Ewing, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 1648 Highway 95, Bullhead City, AZ 86442 Phone: 928-758-4114 Fax: 928-758-4650 |